middle.news
Next Science Navigates Sales Dip Amid $50M Asset Sale Deal
9:07am on Thursday 31st of July, 2025 AEST
•
Healthcare
Read Story
Next Science Navigates Sales Dip Amid $50M Asset Sale Deal
9:07am on Thursday 31st of July, 2025 AEST
Key Points
2Q FY25 product sales fell 10% to US$5.2 million
Direct sales dropped 26%, offset by growth in XPERIENCE and BLASTX
Gross margin improved to 82% due to product mix changes
Cash balance declined to US$1.0 million with US$4.5 million debt
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Next Science (ASX:NXS)
OPEN ARTICLE